In re Hansen Medical Inc. Stockholder Litigation

Court of Chancery of Delaware·Decided June 18, 2018·No. 12316-VCMR·Published

Opinion

IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE

IN RE HANSEN MEDICAL, INC. ) STOCKHOLDERS LITIGATION ) C.A. No. 12316-VCMR

MEMORANDUM OPINION

Date Submitted: March 6, 2018 Date Decided: June 18, 2018

Carmella P. Keener, ROSENTHAL, MONHAIT & GODDESS, P.A., Wilmington, Delaware; Carl L. Stine, Matthew Insley-Pruitt, and Adam J. Blander, WOLF POPPER LLP, New York, New York; Lead Counsel for Plaintiffs.

C. Barr Flinn, Kathaleen S. McCormick, Richard J. Thomas, and M. Paige Valeski, YOUNG CONAWAY STARGATT & TAYLOR, LLP, Wilmington, Delaware; Tariq Mundiya, Benjamin P. McCallen, and Casey Donnelly, WILLKIE FARR & GALLAGHER LLP, New York, New York; Attorneys for Defendants Jack W. Schuler, Jack W. Schuler Living Trust, Renate Schuler, Schuler Family Foundation, Tino Hans Schuler Trust, Tanya Eve Schuler Trust, Therese Heidi Schuler Trust, Larry N. Feinberg, Oracle Partners, L.P., Oracle Ten Fund Master, LP, Oracle Institutional Partners, L.P., the Feinberg Family Foundation, Oracle Investment Management, Inc. Employees’ Retirement Plan, and Feinberg Family Trust

Stephen C. Norman, Brian C. Ralston, and Jacqueline A. Rogers, POTTER ANDERSON & CORROON LLP, Wilmington, Delaware; Sara B. Brody, SIDLEY AUSTIN LLP, San Francisco, California; Matthew J. Dolan, SIDLEY AUSTIN LLP, Palo Alto, California; Attorneys for Defendants Cary G. Vance and Christopher P. Lowe

Raymond J. DiCamillo, Sarah A. Clark, and Ryan P. Durkin, RICHARDS, LAYTON & FINGER, P.A, Wilmington, Delaware; Rocky C. Tsai, ROPES & GRAY LLP, San Francisco, California; John D. Donovan, Jr., ROPES & GRAY LLP, Boston, Massachusetts; Martin J. Crisp, ROPES & GRAY LLP, New York, New York; Timothy R. Farrell, ROPES & GRAY LLP, Chicago, Illinois; Attorneys for Defendant Auris Surgical Robotics, Inc.

MONTGOMERY-REEVES, Vice Chancellor.

This case arises from a squeeze-out merger. The plaintiffs, representing a purported class of minority stockholders, allege that a group of significant stockholders, who together controlled more than fifty percent of the acquired company, used their control of the company to negotiate a beneficial deal for themselves at the expense of the minority stockholders. The defendants have moved to dismiss for failure to state a claim under Court of Chancery Rule 12(b)(6). When the Court of Chancery reviews whether a complaint has stated a claim for which relief can be granted, a fairly lenient standard of review applies. The Court must determine if it is reasonably conceivable, based on the well-pled facts in the complaint, that the plaintiffs can recover.

Under this somewhat lenient standard, the plaintiffs have pled sufficient facts to state a reasonably conceivable claim that a group of stockholders acted as a control group and extracted a different benefit for themselves from the merger transaction. Thus, the plaintiffs have overcome the Rule 12(b)(6) hurdle, and their claims, other than the aiding and abetting claim, survive the defendants’ motions to dismiss.

I. BACKGROUND All facts are drawn from Plaintiffs’ Verified Amended Consolidated Class

Action Complaint (the “Complaint”) and the documents incorporated therein. 1

1 In re Morton’s Rest. Gp., Inc. S’holders Litig., 74 A.3d 656, 658 n.3 (Del. Ch. 2013).

A. Parties and Relevant Non-Parties Hansen Medical Inc. (“Hansen” or the “Company”) is a Delaware corporation, with principal executive offices in Mountain View, California.2 It designs, develops, and markets medical robotics.3 Defendant Cary G. Vance (“Vance”) served as President, Chief Executive Officer (“CEO”), and a director of the Company beginning on May 23, 2014.4 Defendant Cristopher P. Lowe (“Lowe” together with Vance, the “Director Defendants”) served as a director and interim Chief Financial Officer (“CFO”) of the Company. 5 Lowe also served as interim CEO from February to May 2014. 6 Defendant Jack W. Schuler controlled Jack W. Schuler Living Trust, Renate Schuler, Schuler Family Foundation, Tino Hans Schuler Trust, Tanya Eve Schuler Trust, and Therese Heidi Schuler Trust (collectively, “Schuler”), each of which were, at all relevant times, Hansen stockholders. 7 Schuler controlled approximately

2 Compl. ¶ 12. After being identified initially, individuals are referenced herein by their surnames without regard to formal titles such as “Doctor.” No disrespect is intended.

3 Id.

4 Id. ¶ 13.

5 Id. ¶ 14.

6 Id.

7 Id. ¶ 16.

thirty-four percent of Hansen stock.8 Schuler served as a director of the Company from 2013 to January 12, 2016.9 Defendant Larry N. Feinberg, a Hansen stockholder, controlled Defendants Oracle Partners, L.P., Oracle Ten Fund Master, LP, Oracle Institutional Partners, L.P., Feinberg Family Foundation, Oracle Investment Management, Inc. Employees’ Retirement Plan, and Feinberg Family Trust (collectively, “Feinberg” and together with Schuler, the “Controller Defendants”). 10 Feinberg controlled approximately thirty-one percent of Hansen stock.11 Defendant Auris Surgical Robotics, Inc. (“Auris”) is a Delaware corporation based in Silicon Valley that designs and develops robotics for medical applications.12 Auris is not publicly traded. 13 Auris’s co-founder and CEO is Hansen founder

8 Id.

9 Id.

10 Id. ¶ 17.

11 Id.

12 Id. ¶ 18.

13 Id.

Frederic Moll (“Moll”). 14 Moll has served as Chairman of the Board of Auris since June 2011. 15 B. Facts The Complaint incorporates by reference, and relies heavily upon, the Schedule 14A filed by Hansen on June 20, 2016 (the “Proxy”), which Defendants provided as an exhibit to one of the motions to dismiss. The Complaint also incorporates and relies upon the Deposition of Cristopher P. Lowe, taken on July 8, 2016, in a different matter. The parties did not submit the deposition with their filings. Therefore, I include only the facts available in the Complaint and the Proxy. As required when considering a motion to dismiss pursuant to Court of Chancery Rule 12(b)(6), I take all well-pled facts in the Complaint as true. I address only the facts necessary to decide these Motions to Dismiss.

1. The Controller Defendants’ history The Controller Defendants have been investing together since at least 1997.

In 1997, the Controller Defendants filed a Schedule 13DA with the SEC “stating that ‘they may be deemed to be a “group”’ of stockholders in Quidel Corporation.”16 Today, the Controlling Defendants “control almost 25% of the Quidel Corporation’s

14 Id.

15 Id.

16 Id. ¶ 36(a).

stock and Schuler is a member of the Board of Directors.” 17 The Controlling Directors also both invested in Ventana Medical Systems (“Ventana”), and again, Schuler served on the Board of Directors. 18 When Roche Holdings bought out Ventana, Feinberg told Forbes.com that his “strategy [had] been to go along with [Schuler].” 19 The Controller Defendants both currently have substantial investments in Accelerate Diagnostics, Inc., Contrafact Corporation, and Vermillion, Inc., and they have in the past simultaneously owned large stakes in Mazor Robotics, Ltd., Transition Therapeutics, Inc., and Biolase, Inc.20 The Controller Defendants also have acted in concert when dealing with their Hansen holdings. In 2011, they both began their investments in Hansen by participating in a private placement. 21 They were the only participants in the transaction.22 In August 2013, they again both participated in a private placement and increased their shares of Hansen. 23 In 2015, they again participated in a private

17 Id.

18 Id. ¶ 36(b).

19 Id.

20 Id. ¶¶ 36(e)-(f).

21 Id. ¶ 32.

22 Id.

23 Id. ¶ 33.

Free access — add to your briefcase to read the full text and ask questions with AI

In re Hansen Medical Inc. Stockholder Litigation, (Del. Ct. App. 2018).

In re Hansen Medical Inc. Stockholder Litigation (In re Hansen Medical Inc. Stockholder Litigation) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

TSC Industries, Inc. v. Northway, Inc.
426 U.S. 438 (Supreme Court, 1976)
Malone v. Brincat
722 A.2d 5 (Supreme Court of Delaware, 1998)
Superwire. Com, Inc. v. Hampton
805 A.2d 904 (Court of Chancery of Delaware, 2002)
Feldman v. Cutaia
951 A.2d 727 (Supreme Court of Delaware, 2008)
Cinerama, Inc. v. Technicolor, Inc.
663 A.2d 1156 (Supreme Court of Delaware, 1995)
Malpiede v. Townson
780 A.2d 1075 (Supreme Court of Delaware, 2001)
In Re General Motors (Hughes) Shareholder Litigation
897 A.2d 162 (Supreme Court of Delaware, 2006)
Orman v. Cullman
794 A.2d 5 (Court of Chancery of Delaware, 2002)
Kahn v. Lynch Communication Systems, Inc.
638 A.2d 1110 (Supreme Court of Delaware, 1994)
Rosenblatt v. Getty Oil Co.
493 A.2d 929 (Supreme Court of Delaware, 1985)
Savor, Inc. v. FMR Corp.
812 A.2d 894 (Supreme Court of Delaware, 2002)
Penn Mart Realty Company v. Becker
298 A.2d 349 (Court of Chancery of Delaware, 1972)
Cede & Co. v. Technicolor, Inc.
634 A.2d 345 (Supreme Court of Delaware, 1994)
Feldman v. Cutaia
956 A.2d 644 (Court of Chancery of Delaware, 2007)
In Re Primedia Inc. Derivative Litigation
910 A.2d 248 (Court of Chancery of Delaware, 2006)
Gantler v. Stephens
965 A.2d 695 (Supreme Court of Delaware, 2009)
In re KKR Financial Holdings LLC Shareholder Litigation
101 A.3d 980 (Court of Chancery of Delaware, 2014)
Corwin v. KKR Financial Holdings LLC
125 A.3d 304 (Supreme Court of Delaware, 2015)
RBC Capital Markets, LLC v. Jervis
129 A.3d 816 (Supreme Court of Delaware, 2015)
Appel v. Berkman
180 A.3d 1055 (Supreme Court of Delaware, 2018)